First Pig Kidney Transplant Patient Leaves Hospital with Renewed Health and Hope for Others

Rick Slayman, the recipient of the world’s first pig kidney transplant, is set to leave Massachusetts General Hospital after nearly two weeks since the groundbreaking surgery. The 62-year-old will continue his recovery at home in Weymouth, as announced by the hospital. Slayman expressed his gratitude for the care he received and stated that leaving the hospital with improved health is one of the happiest moments of his life.

At the time of the transplant on March 21, Slayman was battling end-stage kidney disease, Type 2 diabetes, and hypertension. He had previously received a human kidney transplant in 2018, which started failing after five years. This pig kidney transplant marks the first time a pig kidney has been transplanted into a living human patient, a groundbreaking achievement spearheaded by Mass General. The kidney was donated by eGenesis in Cambridge, genetically edited to remove harmful pig genes, with the addition of certain human genes to enhance compatibility.

Slayman’s recovery is progressing smoothly, and he expressed his appreciation for the well-wishes he received from those rooting for his healing journey. He acknowledged the significance of this milestone not just for himself but for other patients awaiting kidney transplants, signaling a new beginning for those hoping for a similar outcome.

The successful outcome of this groundbreaking surgery brings hope to millions of people worldwide who are affected by end-stage renal disease (ERD). ERD affects about 10% of adults worldwide and can lead to complications such as anemia, high blood pressure, and malnutrition if left untreated.

The pig kidney transplant was made possible thanks to years of research and collaboration between scientists and medical professionals at Massachusetts General Hospital. The team worked tirelessly to ensure that the donor organ was safe and compatible with Slayman’s body.

Slayman’s successful recovery from this groundbreaking surgery sets an example for others who are battling ERD. With further advancements in technology and medicine, it may be possible for more people to receive organ transplants in the future.

As Slayman leaves Massachusetts General Hospital with improved health and hope for others who may be facing similar challenges in their lives, we can only imagine how grateful he must feel to have been given this second chance at life.